Imperial Valley News Center
Energy Department Releases Request for Information on Multi-Sector Uses of Hydrogen
- Details
- Written by Green Liver
Chicago, Illinois - At today’s H2@ Scale project kickoff meeting in Chicago, EERE’s Deputy Assistant Secretary for Transportation Steven Chalk announced the release of a request for information (RFI) soliciting stakeholder feedback on opportunities to enable high volume production and multi-sector use of hydrogen.
Northern California fairs step-up to support fire response
- Details
- Written by CDFA
Sacramento, California - With the Carr, Ferguson, Mendocino Complex, Whaleback and Natchez fires continuing to burn in Shasta County, Lassen County, Mariposa County, Mendocino County, and Del Norte County–not to mention a number of additional fires–California’s network of fairs is fulfilling a crucial role as staging areas for fire crews, and serving as evacuation centers for people and animals. The following fairgrounds are serving during the current spate of wildfires.
FDA supports critical research to spur innovation for continuous manufacturing technology to support and advance drug and biologics development
- Details
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration awarded three grants, using its authority under the 21st Century Cures Act, to institutions of higher education and non-profit organizations to study and recommend improvements for the continuous manufacturing of drugs and biological products, as well as similar innovative monitoring and control techniques. The grant awardees are:
Careful oversight of the REMS associated with transmucosal immediate-release fentanyl products
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D.
Washington, DC - On August 3, the U.S. Food and Drug Administration will be hosting a public advisory committee meeting to review data from the most recent assessment of the Risk Evaluation and Mitigation Strategy (REMS) with Elements to Assure Safe Use (ETASU) for transmucosal immediate-release fentanyl (TIRF) products. The FDA will be asking the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee to discuss the findings from the assessments conducted by manufacturers of these products, as well as additional data about their use patterns and adverse events. Asking the FDA’s advisory committees to take a closer look at this opioid-related REMS reflects our commitment to further evaluating this critical program and making sure we’re providing transparency around its effectiveness and whether any modifications may be necessary.
The Republic of Benin's Independence Day
- Details
- Written by State Department
Washington, DC - Secretary of State Michael R. Pompeo: "On behalf of the Government of the United States of America, I send our best wishes to the people of Benin as they celebrate 58 years of independence.
Is your work-life balance out of balance?
- Details
- Written by Mayo Clinic Staff
Rochester, Minnesota - There was a time when the boundaries between work and home were fairly clear. Today, however, work is likely to invade your personal life — and maintaining work-life balance is no simple task.
Page 1189 of 3785